PFF Webinar Library

fda-stamp-of-approval-and-medications

The FDA's Drug Approval Process

Fri, Sep 28, 2018

Learn about FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Dr. Banu Karimi-Shah of the FDA - Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology Products joins us to give background information on the FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Recent Webinars

  • airplane-in-the-sky
    Dec
    03
    2025

    On the Move with Oxygen: A Travel Guide for Pulmonary Fibrosis Patients | Virtual

    View Webinar
  • two-people-genetics
    Sep
    10
    2025

    Genetics and Beyond: Exploring Interstitial Lung Disease in Families and Individuals | Virtual

    View Webinar
  • pyramids-in-desert
    Aug
    27
    2025

    Building the Evidence Pyramid: What Makes Research Reliable? | Virtual

    View Webinar
  • Jul
    23
    2025

    Managing Pulmonary Hypertension and Interstitial Lung Disease: Symptoms, Tests, and Treatment

    View Webinar